ROCK

下级目录

AT13148

目录项下的产品

1056901-62-2

1056901-62-2 / MFCD156901622
AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors. AT13148 is currently being developed by Astex Pharmaceuticals. AT131148 was identified utilizing high-throughput X-ray crystallography and fragment-based lead discovery techniques. AT13148 caused substantial blockade of AKT, p70S6K, PKA, ROCK and SGK substrate phosphorylation and induction of apoptosis in both a concentration and time-dependent manner in cancer cells with clinically relevant genetic defects both in vitro and in vivo.

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

Products Indices

Mailings

Contact

BIZ@labnovo.com
QQ: 2486526651

链接

LAB{novo} Technical Notes

京ICP备2020036287号